Thursday, May 30, 2019

What Exactly Is Benicar Lawsuit Settlement?

When Benicar was first approved by the U.S. Food and Drug Administration for treating high blood pressure in 2002, both physicians and public hailed it as a superior treatment option to existing drugs at the time. Unfortunately, countless people have suffered from adverse and unexpected side effects which include serious pregnancy-related risks such as fetal toxicity and intestinal problems like sprue-like enteropathy.
Benicar (olmesartan medoxomil) is a type of angiotensin II receptor blocker (ARB). The U.S. Food and Drug Administration (FDA) approved the drug for the U.S. market as a safe and effective treatment of high blood pressure, or hypertension in adults.

Studies have shown that women who take Benicar during pregnancy, especially during the second and third trimesters, may put the fetus at risk of fetal kidney failure and other complications. The health effects found are skeletal deformations, skull hypoplasia, anuria, low blood pressure, and death. For all these, Benicar carries a black-box warning — the strongest warning on a drug label.
Fifteen Benicar lawsuits settlements were consolidated in 2015 by the federal judges as a multidistrict litigation (MDL) which was against Daiichi and Forest Labs. MDLs allow the federal courts to make the similar cases into a single one and thus save on money and time for the plaintiffs as well as for the court.
The FDA previously sent Benicar manufacturer, Daiichi Sankyo, a warning regarding the manufacturer’s false advertising of Benicar. In 2010, the FDA released a warning that Benicar may increase the risk of death in diabetic patients.
As early as 2006, drugmaker Sankyo has been accused of misleading marketing tactics that violated FDA regulations. The FDA sent another letter with similar claims that the Benicar marketing campaign was misleading in 2013. Prior to the FDA warning, in 2012, there was a study which showed 22 patients been hospitalized and were presented with symptoms similar to celiac disease.
Lawyers have joined the Benicar lawsuit with individuals that suffered serious injuries and damages as a result of their Benicar usage. If you have questions about the lawsuit and how to deal with it, get in touch with the team of Benicar411.info. Call 855-297-1131 to know more about the lawsuit and get a free, legal consultation.

No comments:

Post a Comment

Complications That Has Always Been In Discussion For Benicar

Benicar is the brand name of a drug which has olmesartan medoxomil as the active ingredient. It is part of a class of medications known as...